Home » Topics » Regulatory » Patents

Patents
RSS

Immunosuppressant S1P1 receptor agonists prepared and tested at Merck & Co.

Sep. 12, 2005

New agents for treating hepatitis C infection disclosed by Japan Tobacco

Sep. 12, 2005

Astellas Pharma discloses novel therapeutic agents for bone disorders

Sep. 12, 2005

New therapeutic agents for cancer disclosed in recent patents

Sep. 12, 2005

MMP inhibitors for arthritis emerge from Japan Tobacco R&D

Sep. 9, 2005

Novel diagnostic agents disclosed by Amersham

Sep. 9, 2005

New treatments for psychosis and depression in early development

Sep. 9, 2005

Recent patents cover novel treatments for neurodegenerative disorders

Sep. 9, 2005

New therapeutic agents for renal diseases in early development at Astellas Pharma

Sep. 8, 2005

Recent patent describes novel antimalarial agents

Sep. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...